Document Detail


Effect of dapoxetine on the pharmacokinetics and hemodynamic effects of tamsulosin in men on a stable dose of tamsulosin.
MedLine Citation:
PMID:  18832488     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The tolerability of dapoxetine, a short-acting selective serotonin reuptake inhibitor being developed for premature ejaculation, was evaluated when coadministered with tamsulosin. Adult men on a stable dose of tamsulosin were randomized to also receive dapoxetine 30 or 60 mg, or placebo, in a crossover design. Supine and standing vital signs were measured on days 1 and 7. Plasma samples were collected for measurement of tamsulosin, dapoxetine, and dapoxetine metabolites. Coadministration of dapoxetine with tamsulosin did not alter orthostatic profiles or affect the incidence of orthostatic hypotension. Tamsulosin and dapoxetine pharmacokinetics were not altered. Adverse events were reported by 5.4%, 10.9%, and 23.2% of participants receiving tamsulosin with placebo, dapoxetine 30 mg, and dapoxetine 60 mg, respectively. The most common adverse events were diarrhea, dizziness, headache, and nausea. Therefore, dapoxetine had no clinically important effects on the pharmacokinetics or orthostatic profile of tamsulosin in men on a stable tamsulosin regimen.
Authors:
N B Modi; S Kell; J Aquilina; D Rivas
Related Documents :
20684158 - Cutaneous fixed drug eruption to fluconazole.
21838178 - The physician's relationship with the pharmaceutical industry: caveat emptor...buyer be...
2928498 - The influence of film-screen color sensitivity and type of measurement device on kvp me...
19877368 - Revised medical criteria for evaluating malignant neoplastic diseases. final rule.
10196718 - Acoustic properties of nc100100 and their relation with the microbubble size distribution.
19723488 - Trends in types of dermatology books available over the last ten years.
Publication Detail:
Type:  Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-10-02
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  48     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-12-02     Completed Date:  2009-02-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1438-50     Citation Subset:  IM    
Affiliation:
Clinical Pharmacology, ALZA Corporation, Mountain View, California USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / adverse effects,  pharmacokinetics,  pharmacology
Adult
Aged
Area Under Curve
Benzylamines / adverse effects,  pharmacokinetics*,  pharmacology
Cross-Over Studies
Dizziness / chemically induced
Double-Blind Method
Half-Life
Headache / chemically induced
Hemodynamics / drug effects*
Humans
Hypotension, Orthostatic / chemically induced
Male
Middle Aged
Naphthalenes / adverse effects,  pharmacokinetics*,  pharmacology
Receptors, Adrenergic, alpha-1 / antagonists & inhibitors
Serotonin Uptake Inhibitors / adverse effects,  metabolism,  pharmacokinetics,  pharmacology
Sulfonamides / adverse effects,  pharmacokinetics*,  pharmacology
Syncope, Vasovagal / chemically induced
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Benzylamines; 0/Naphthalenes; 0/Receptors, Adrenergic, alpha-1; 0/Serotonin Uptake Inhibitors; 0/Sulfonamides; 106133-20-4/tamsulosin; 119356-77-3/dapoxetine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cyclical loading of coracoclavicular ligament reconstructions: a comparative biomechanical study.
Next Document:  Telling interviewers about sexual abuse: predictors of child disclosure at forensic interviews.